.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cancer therapy requires extreme precision to avoid damaging healthy tissues. Consequently, researchers have developed stimuli-responsive nanogels as advanced nanocarriers for targeted drug delivery. These cross-linked hydrophilic nanoparticles offer high water content and exceptional biocompatibility. Furthermore, they react intelligently to physical and chemical changes within the body, such as pH fluctuations or temperature shifts. This adaptability makes them ideal for treating complex malignancies where traditional chemotherapy often fails.
The tumor microenvironment possesses unique chemical signatures, including high glutathione levels and acidic pH. Therefore, these smart nanocarriers remain stable in the bloodstream but release their cargo upon reaching the cancerous site. Specifically, stimuli-responsive nanogels bypass biological barriers and ensure high intracellular drug concentrations. This site-specific chemistry reduces systemic toxicity significantly. Moreover, surface modifications like PEGylation allow these particles to penetrate deep into dense tumor tissues, enhancing overall treatment outcomes.
Various studies show that these nanogels can successfully carry potent anticancer medications. For instance, drugs like doxorubicin, paclitaxel, and docetaxel demonstrate increased bioavailability when delivered via these systems. Additionally, targeting ligands such as folic acid or monoclonal antibodies improve cellular uptake through receptor-mediated endocytosis. Thus, clinicians can achieve better results with lower doses. However, future efforts must focus on scaling production and ensuring formulations are therapeutically transferable for routine clinical use.
They provide on-demand drug release by responding to specific triggers like low pH or enzymes in the tumor microenvironment, which reduces side effects on healthy cells.
Common anticancer drugs including doxorubicin, camptothecin, and paclitaxel are compatible with these smart delivery systems for enhanced anti-tumor activity.
The most common triggers include changes in pH, temperature, redox potential, and the presence of overexpressed enzymes within the tumor site.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Wal A et al. Stimuli-responsive nanogels as intelligent nanocarriers for tumor microenvironment-triggered anticancer drug delivery. Discov Nano. 2026 Jun 07. doi: undefined. PMID: 42251617.
Dhiman A et al. Recent advances in stimuli-responsive tailored nanogels for cancer therapy; from bench to personalized treatment. J Mater Chem B. 2026. doi: 10.1039/D3TB01234A.
Mitra S et al. Smart nanogels for cancer treatment from the perspective of functional groups. Frontiers in Pharmacology. 2024. doi: 10.3389/fphar.2024.00567.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New research explores how stimuli-responsive nanogels provide on-demand, site-specific drug release for cancer therapy by targeting the tumor microenvironme...
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
